Related Experiment Video
Updated: Jul 26, 2026
07:01
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
Published on: April 17, 2013
21.0K
ENDOCAN TUTHYREF network consensus recommendations: Anaplastic thyroid cancer
Livia Lamartina1, Arnaud Jannin2, Myriam Decaussin-Petrucci3
1Département d'imagerie médicale, service de cancérologie endocrinienne, Gustave-Roussy, 94805 Villejuif, France.
Annales D'Endocrinologie
|May 11, 2025
Summary
Anaplastic thyroid cancer (ATC) is aggressive. Prompt diagnosis and multidisciplinary care are crucial for managing this rare disease, with new targeted treatments offering future hope.
Area of Science:
- Oncology
- Endocrinology
Background:
- Anaplastic thyroid cancer (ATC) is a rare, aggressive endocrine neoplasm with a poor prognosis.
- Clinical suspicion arises from rapid growth and stony neck masses, necessitating urgent diagnostic work-up.
Framework:
- Management requires a multidisciplinary team approach, including specialists, support care, and geriatric oncology if needed.
- Assessment must consider disease extent, comorbidities, patient's overall health, and personal preferences.
Implementation:
- Realistic prognostic information should be provided to patients and families.
- Treatment strategies include active therapy alongside supportive care or exclusive palliative care from diagnosis.
Implications:
- Despite challenges, advances in tumor molecular profiling, targeted therapies, and immunotherapy present promising future directions for ATC management.
- These consensus recommendations from the ENDOCAN TUTHYREF network offer a framework for optimizing ATC patient care.
